-
1
-
-
0026517115
-
Long-term weight control: The National Heart, Lung, and Blood Institute funded multimodal intervention study
-
Weintraub M. Long-term weight control: the National Heart, Lung, and Blood Institute funded multimodal intervention study. Clin Pliannacol Hier 1992; 51: 581.
-
(1992)
Clin Pliannacol Hier
, vol.51
, pp. 581
-
-
Weintraub, M.1
-
2
-
-
0028139089
-
Positional cloning of the mouse ob gene and its human homologue
-
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse ob gene and its human homologue. Nature 1994; 372: 425-432.
-
(1994)
Nature
, vol.372
, pp. 425-432
-
-
Zhang, Y.1
Proenca, R.2
Maffei, M.3
Barone, M.4
Leopold, L.5
Friedman, J.M.6
-
3
-
-
13344295079
-
Serum immunoreactive-leptin concentrations in normal-weight and obese humans
-
Considine RV, Sinha MK, Heiman ML et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. New Engl J Med 1996; 334: 292-295.
-
(1996)
New Engl J Med
, vol.334
, pp. 292-295
-
-
Considine, R.V.1
Sinha, M.K.2
Heiman, M.L.3
-
4
-
-
0028978910
-
Genetic variation in the beta3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity
-
Clement K, Vaisse C, Manning BS et al. Genetic variation in the beta3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. New Engl J Med 1995; 333: 352-354.
-
(1995)
New Engl J Med
, vol.333
, pp. 352-354
-
-
Clement, K.1
Vaisse, C.2
Manning, B.S.3
-
5
-
-
33646856669
-
Weighing the Options: Criteria for Evaluating Weight-Management Programs
-
Committee to Develop Criteria for Evaluating the Outcomes of Approaches to Prevent and Treat Obesity. Weighing the Options: Criteria for Evaluating Weight-Management Programs. Washington, DC: National Academy Press, 1995: 5.
-
(1995)
Washington, DC: National Academy Press
, pp. 5
-
-
-
6
-
-
0024446507
-
International trial of long-term dexfenfluramine in obesity
-
Guy-Grand B, Apfelbaum M, Crepaldi G, Gries A, Lefebvre P, Turner P. International trial of long-term dexfenfluramine in obesity. Lancet 1989; 2: (8672) 1142-1145.
-
(1989)
Lancet
, vol.2
, Issue.8
, pp. 1142-1145
-
-
Guy-Grand, B.1
Apfelbaum, M.2
Crepaldi, G.3
Gries, A.4
Lefebvre, P.5
Turner, P.6
-
7
-
-
0026753155
-
Beneficial effects of modest weight loss
-
Goldstein DS. Beneficial effects of modest weight loss. Int J Obesity 1992; 16: 397-415.
-
(1992)
Int J Obesity
, vol.16
, pp. 397-415
-
-
Goldstein, D.S.1
-
8
-
-
0025808739
-
The heterogenecity of obesity: Fitting treatments to individual
-
Brownell KD, Wadden TA. The heterogenecity of obesity: fitting treatments to individual. Behav Tlier 1991; 22: 153-177.
-
(1991)
Behav Tlier
, vol.22
, pp. 153-177
-
-
Brownell, K.D.1
Wadden, T.A.2
-
9
-
-
0025080094
-
Long-term effects of dieting on resting metabolic rate in obese outpatients
-
Wadden TA, Foster GD, Letizia KA, Müllen JL. Long-term effects of dieting on resting metabolic rate in obese outpatients. JAMA 1990; 264: 707-711.
-
(1990)
JAMA
, vol.264
, pp. 707-711
-
-
Wadden, T.A.1
Foster, G.D.2
Letizia, K.A.3
Müllen, J.L.4
-
10
-
-
0030638144
-
Position of the American Dietetic Association on Weight Management
-
The American Dietetic Association. Position of the American Dietetic Association on Weight Management. J Am Dietetic Assoc 1997; 1: 71-74.
-
(1997)
J Am Dietetic Assoc
, vol.1
, pp. 71-74
-
-
-
11
-
-
0026596002
-
Metabolic consequences of fenfluramine for the control of body weight
-
Levitsky DA, Troiano R. Metabolic consequences of fenfluramine for the control of body weight. AmJ Clin Nutrition 1992; 55: 167S-172S.
-
(1992)
AmJ Clin Nutrition
, vol.55
-
-
Levitsky, D.A.1
Troiano, R.2
-
12
-
-
0030593413
-
Dexfenfluramine for obesity
-
Editorial Staff. Dexfenfluramine for obesity. Med Letter 1996; 38: 64-65.
-
(1996)
Med Letter
, vol.38
, pp. 64-65
-
-
-
13
-
-
0029799509
-
Pharmacotherapy for obesity: Do the benefits outweigh the risks? [editorial]
-
Manson JE, Faich GA. Pharmacotherapy for obesity: Do the benefits outweigh the risks? [editorial]). New EnglJ Med 1996; 335: 659-660.
-
(1996)
New EnglJ Med
, vol.335
, pp. 659-660
-
-
Manson, J.E.1
Faich, G.A.2
-
14
-
-
0028295544
-
Dexfenfluramine reduces cardiovascular risk factors
-
Bremer JM, Russell S, Lintott CJ. Dexfenfluramine reduces cardiovascular risk factors. IntJ Obesity 1994; 18: 199-205.
-
(1994)
IntJ Obesity
, vol.18
, pp. 199-205
-
-
Bremer, J.M.1
Russell, S.2
Lintott, C.J.3
-
15
-
-
0026549721
-
The effects of dexfenfluramine on blood glucose control in patients with type 2 diabetes
-
Willey KA, Molyneaux LM, Overland JE, Yue DK. The effects of dexfenfluramine on blood glucose control in patients with type 2 diabetes. Diabetic Med 1992; 9: 341-343.
-
(1992)
Diabetic Med
, vol.9
, pp. 341-343
-
-
Willey, K.A.1
Molyneaux, L.M.2
Overland, J.E.3
Yue, D.K.4
-
16
-
-
0027526493
-
Dexfenfluramine in type E diabetes: Effect on weight and diabetes control
-
Stewart GO, Stein GR, Davis TM, Findlater P. Dexfenfluramine in type E diabetes: effect on weight and diabetes control. Med J Australia 1993; 158: 167-169.
-
(1993)
Med J Australia
, vol.158
, pp. 167-169
-
-
Stewart, G.O.1
Stein, G.R.2
Davis, T.M.3
Findlater, P.4
-
18
-
-
10544235698
-
Long-term pharmacotherapy in the management of obesity
-
National Task Force on the Prevention and Treatment of Obesity. Long-term pharmacotherapy in the management of obesity. JAMA 1996; 276: 1907-1915.
-
(1996)
JAMA
, vol.276
, pp. 1907-1915
-
-
-
19
-
-
0028889089
-
Neuroendocrine abnormalities in human obesity
-
Bjorntorp P. Neuroendocrine abnormalities in human obesity. Metabolism 1995; 44: 38-41.
-
(1995)
Metabolism
, vol.44
, pp. 38-41
-
-
Bjorntorp, P.1
-
20
-
-
0021923986
-
D-fenfluramine selectively suppresses carbohydrate snacking by obese subjects
-
Wurtman JJ, Wurtman RJ, Tsay MS et al. D-fenfluramine selectively suppresses carbohydrate snacking by obese subjects. Int J Eating Disorders 1985; 4: 89-99.
-
(1985)
Int J Eating Disorders
, vol.4
, pp. 89-99
-
-
Wurtman, J.J.1
Wurtman, R.J.2
Tsay, M.S.3
-
21
-
-
0029834936
-
Serotoninergic drug-induced weight loss in carbohydrate craving obese patients
-
Toornvliet AC, Fiji H, Hopman E, Elte-de Wever BM, Meinders AE. Serotoninergic drug-induced weight loss in carbohydrate craving obese patients. IntJ Obesity Related Metab Disorders 1996; 20: 917-920.
-
(1996)
IntJ Obesity Related Metab Disorders
, vol.20
, pp. 917-920
-
-
Toornvliet, A.C.1
Fiji, H.2
Hopman, E.3
Elte-de Wever, B.M.4
Meinders, A.E.5
|